Scanlon Meghan 4
4 · BOSTON SCIENTIFIC CORP · Filed Feb 22, 2022
Insider Transaction Report
Form 4
Scanlon Meghan
SVP,Pres,Urology Pelvic Health
Transactions
- Tax Payment
Common Stock
2022-02-17$42.83/sh−494$21,158→ 20,951 total - Exercise/Conversion
Common Stock
2022-02-17+1,583→ 21,445 total - Exercise/Conversion
Common Stock
2022-02-18+1,112→ 22,063 total - Tax Payment
Common Stock
2022-02-18$42.55/sh−327$13,914→ 21,736 total - Exercise/Conversion
Deferred Stock Units
2022-02-18−1,112→ 2,224 totalExp: 2024-02-18→ Common Stock (1,112 underlying) - Exercise/Conversion
Restricted Stock Units
2022-02-17−1,583→ 4,750 totalExp: 2025-02-17→ Common Stock (1,583 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.